MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
1,899,348
Share change
+639,029
Total reported value
$120,586,114
Price per share
$63.57
Number of holders
47
Value change
+$40,649,356
Number of buys
18
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q3 2014

As of 30 Sep 2014, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,899,348 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, BARCLAYS PLC, NIEMANN CAPITAL MANAGEMENT INC, MORGAN STANLEY, HighTower Advisors, LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, ENVESTNET ASSET MANAGEMENT INC, MACROVIEW INVESTMENT MANAGEMENT LLC, and UNITED CAPITAL FINANCIAL ADVISERS, LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.